Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Operating Expenses (2016 - 2025)

Historic Operating Expenses for INVO Fertility (IVF) over the last 17 years, with Q3 2025 value amounting to $3.4 million.

  • INVO Fertility's Operating Expenses rose 2410.87% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.1 million, marking a year-over-year increase of 15925.18%. This contributed to the annual value of $14.7 million for FY2024, which is 4975.38% up from last year.
  • Per INVO Fertility's latest filing, its Operating Expenses stood at $3.4 million for Q3 2025, which was up 2410.87% from $4.9 million recorded in Q2 2025.
  • INVO Fertility's Operating Expenses' 5-year high stood at $18.7 million during Q1 2025, with a 5-year trough of $1.9 million in Q3 2023.
  • Moreover, its 5-year median value for Operating Expenses was $2.8 million (2022), whereas its average is $3.8 million.
  • Per our database at Business Quant, INVO Fertility's Operating Expenses skyrocketed by 20001201.92% in 2021 and then tumbled by 3258.38% in 2023.
  • Quarter analysis of 5 years shows INVO Fertility's Operating Expenses stood at $2.5 million in 2021, then rose by 19.98% to $3.0 million in 2022, then dropped by 3.54% to $2.9 million in 2023, then skyrocketed by 78.19% to $5.2 million in 2024, then tumbled by 34.13% to $3.4 million in 2025.
  • Its Operating Expenses was $3.4 million in Q3 2025, compared to $4.9 million in Q2 2025 and $18.7 million in Q1 2025.